Blood transfusions in the critically III patient

Disease-a-Month

Volumn 45, Issue 10, 1999, Pages 411-426

  Corwin, Howard L ^a,b,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Critical Care Medicine   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

BLOOD TRANSFUSION; CLINICAL PRACTICE; CRITICAL ILLNESS; HEMATOCRIT; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; PHLEBOTOMY; REVIEW; TREATMENT INDICATION;

EID: 0032741193     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Spence RK, Cernaianu AC, Carson J, Del Rossi AJ: Transfusion and surgery. Current Problems in Surgery 1993;Dec;30(12):1101-80.
2. Consensus Conference: perioperative red blood cell transfusion. JAMA 1988;260:2700-3.
3. Practice strategies for elective blood cell transfusion. Ann Intern Med 1992;116:403-406.
4. Welch HG, Meehan KR, Goodnough LT. Prudent strategies for elective red blood cell transfusion. Ann Intern Med 1992;116:393-402.
5. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine: Blood transfusion. N Engl J Med 1999;340:438-47.
6. Walker RH. Transfusion risks. Am J Clin Pathol 1987;88:374-8.
7. Blumberg N, Heal JM. Effects of transfusion on immune function. Arch Pathol Lab Med 1994;118:371-9.
8. Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996;82:187-204.
9. Mickler TA, Longnecker DE. The immunosuppressive aspects of blood transfusion. J Intensive Care Med 1992;7:176-88.
10. Vamvakas EC, Craven JH. Allogenic blood transfusion, hospital charges, and length of hospitalization: A study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998;122:145-51.
11. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leukocyte depleted versus buffy coat poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841-5.
12. Blumberg N, Heal JM. Blood transfusion: The silent epidemic. Arch Pathol Lab Med 1998;122:117-8.
13. American Association of Blood Banks. BPAC recommends universal leukoreduction. AABB News Briefs 1998;20:16.
14. Moore FA, Moore EE, Sauaia A. Blood transfusion: An independent risk factor for postinjury multiple organ failure. Arch Surg 1997;132:620-5.
15. Littenberg B, Corwin HC, Gettinger A, Leichter J, AuBuchon J. A practice guideline and decision aide for blood transfusion. Immunohematology 1995;11:88-94.
16. Corwin HC, Parsonnet KC, Gettinger A. RBC transfusion in the ICU: Is there a reason? Chest 1995;108:767-71.
17. Groeger JS, Guntupalli KK, Strosberg M, Halpern N, Raphaely RC, Cerra F, Kaye W. Descriptive analysis of critical care units in the United States: Patient characteristics and intensive care unit utilization. Crit Care Med 1993;21:279-91.
18. Smoller BR, Rruskall MS. Phlebotomy for diagnostic laboratory tests in adults: pattern of use and effect on transfusion requirements. N Engl J Med 1986;314:1233-5.
19. Eyster E, Bernene J. Nosocomial anemia. JAMA 1973;223:73-4.
20. Tarpey J, Lawler PG. Iatrogenic anaemia? A survey of venesection in patients in the intensive therapy unit. Anaesthesia 1990;45:396-8.
21. Muakkassa FF, Rutledge R, Fakhry SM, Meyer AA, Sheldon GF. ABGs and arterial lines: The relationship to unnecessarily drawn arterial blood gas samples. J Trauma 1990;30:1087-95.
22. Low LL, Harrington GR, Stoltzfus DP. The effect of arterial lines on blood-drawing practices and costs in intensive care units. Chest 1995;108:216-9.
23. Brown RB, Klar J, Teres D, Lemeshow S, Sands M. Prospective study of clinical bleeding in intensive care unit patients. Crit Care Med 1988;16:1171-6.
24. Salem-Schatz SR, Avorn J, Soumerai SB. Influence of clinical knowledge, organizational context, and practice style on transfusion decision making. JAMA 1991;264:476-83.
25. Goodnough LT, Johnston MFM, Toy PTCY. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991;265:86-90.
26. Goodnough LT, Soegiarso RW, Birkmeyer JD, Welch HG. Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery. Am J Med 1993;94:509-14.
27. Saxena S, Weiner JM, Rabinowitz A, Fridey J, Shulman IA, Carmel R. Transfusion practice in medical patients. Arch Intern Med 1993;153:2575-80.
28. Mozes B, Epstein M, Ben-Bassat I, Modan B, Halkin H. Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion 1989;29:473-6.
29. Carmel R, Shulman IA. Blood transfusion in medically treatable chronic anemia. Arch Pathol Lab Med 1989;113:995-7.
30. Chernow B, Salem M, Stacey J. Blood conservation - a critical care imperative. Crit Care Med 1991;19:313-314.
31. Chernow B. Blood conservation in critical care - the evidence accumulates. 1993;21:481-2.
32. Foulke GE, Harlow DJ. Effective measures for reducing blood loss from diagnostic laboratory tests in intensive care unit patients. Crit Care Med 1989;1143-5.
33. Smoller BR, Kruskall MS, Horowitz GL. Reducing adult phlebotomy blood loss with the use of pediatric sized blood collection tubes. Am J Clin Pathol 1989;91:701-3.
34. Civetta JM, Hudson-Civetta JA. Maintaining quality of care while reducing charges in the ICU. Ann Surg 1985;202:524-30.
35. Peruzzi WT, Parker MA, Lichtenthal PR, Cochran-Zull C, Toth B, Blake M. A clinical evaluation of a blood conservation device in medical intensive care unit patients. Crit Care Med 1993;21:501-6.
36. Silver MJ, Jubran H, Stein S, McSweeney T, Jubran F. Evaluation of a new blood conserving arterial line system for intensive care units. Crit Care Med 1993;21:507-11.
37. Zimmerman JL, Dellinger RP. Initial evaluation of a new intra-arterial blood gas system in humans. Crit Care Med 1993;21:495-500.
38. Shapiro BA, Mahutte CK, Cane RD, Gilmour IJ. Clinical performance of a blood gas monitor. A prospective multicenter trial. Crit Care Med 1993:21:487-94.
39. Valenstein P, Leiken A, Lehmann. Test-ordering by multiple physicians increases unnecessary laboratory examinations. Arch Pathol Lab Med 1988;112:238-41.
40. Soumerai SB, Salem-Schatz S, Avorn J, Casteris CS, Ross-Degnan D, Popovsky MA. A controlled trial of educational outreach to improve blood transfusion practice. JAMA 1993;270:961-6.
41. Adam RC, Lundy JS. Anesthesia in cases of poor risk. Some suggestions for decreasing the risk. Surg Gynecol Obstet 1942;74:1011-101.
42. Stehling LC, Ellison N, Faust RJ, Grotta AW, Moyers JR. A survey of transfusion practices among anesthesiologists. Vox Sang 1987;52:60-2.
43. Hebert PC, Wells G, Martin C, Tweeddale M, Marshall J, Blajchman M, Pagliarello G, Schweitzer I, Calder L. A Canadian survey of transfusion practices in critically ill patients. Crit Care Med 1998;26:482-7.
44. Levine E, Rosen A, Sehgal L, Gould S, Sehgal H, Moss G. Physiologic effects of acute anemia. Implications for a reduced transfusion trigger. Transfusion 1990;30:11-4.
45. Geha AS. Coronary and cardiovascular dynamics and oxygen availability during acute normovolemic anemia. Surgery 1976;80:47-53.
46. Mathru M, Kleinman B, Blakeman B, Dries D, Zecca A, Rao T. Cardiovascular adjustments and gas exchange during extreme hemodilution in humans. Crit Care Med 1991;19:700-4.
47. Mathru M, Kleinman B, Blakeman B, Sullivan H, Kumar P, Dries DJ. Myocardial metabolism 37 and adaption during extreme hemodilution in humans after coronary revascularization. Crit Care Med 1992;20:1420-5.
48. Weiskopf RB, Viele MK, Feiner J, Kelley S, Liebermen J, Noorani M, Leung JM, Fisher DM, Murray WR, Toy P, Moore MA. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998;279:217-21.
49. Rawstron RE. Anemia and surgery. A retrospective clinical study. Aust NZ J Surg 1970;39:425-32.
50. Alexiu O, Mircea N, Balaban M, Furtunescu B. Gastrointestinal hemorrhage from peptic ulcer. An evaluation of bloodless transfusion and early surgery. Anaesthesia 1975;30:609-15.
51. Lunn JN, Elwood PC. Anaemia and surgery. Br Med J 1970;3:71-3.
52. Carson JL, Spence RK, Poses RM. Severity of anaemia and operative mortality and morbidity. Lancet 1988;1:727-9.
53. Spence RK, Carson JA, Poses R, McCoy S, Pello M, Alexander J, Popovich J, Norcross E, Camishion RC. Elective surgery without transfusion: Influence of preoperative hemoglobin level and blood loss on mortality. Am J Surg 1990;159:320-4.
54. Kitchens CS. Are transfusions overrated? Surgical outcome of Jehovah's Witnesses. Am J Med 1993;94:117-9.
55. Czer LSC, Shoemaker WC. Optimal hematocrit value in critically ill postoperative patients. Surg Gynecol Obstet 1978;147:363-8.
56. Nelson AH, Fleisher LA, Rosenbaum SH. Relationship between postoperative anemia and cardiac morbidity in high-risk vascular patients in the intensive care unit. Crit Care Med 1993;21:860-6.
57. Baxter BT, Minion DJ, McCance CL, Eskildsen JM, Heffele JJ, Lynch TG. Rational approach to postoperative transfusion in high-risk patients. Am J Surg 1993;166:720-5.
58. Geha AS, Baue AE. Graded coronary stenosis and coronary flow during acute normovolemic anemia. World J Surg 2:645-52.
59. Hebert PC, Wells G, Tweddale M, Martin C, Marshall J, Pham BA, Blajchman, Schwietzer I, Pagliarello G. Does transfusion practice affect mortality in critically ill patients. Am J Respir Crit Care Med 1997;155:1618-23.
60. Carson JL. Duff A. Poses RM. Berlin JA. Spence RK. Trout R. Noveck H. Strom BL. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348:1055-60.
61. Dietrich KA, Conrad SA, Hebert CA, Levy GL, Romero MD. Cardiovascular and metabolic response to red blood transfusion in critically ill volume resuscitated patients. Crit Care Med 1990;18:940-4.
62. Lorente JA, Landin L, De Pablo R, Renes E, Rodriguez-Diaz R, Liste D. Effects of blood transfusion on oxygen transport variables in sepsis. Crit Care Med 1993;21:1312-8.
63. Robbins JM, Keating K, Orlando R, Yeston NS. Effects of blood transfusion on oxygen delivery and consumption in critically ill surgical patients. Contemp Surg 1993;43:281-5.
64. Steffes CP, Bender JS, Levison MA. Blood transfusion and oxygen consumption in surgical sepsis. Crit Care Med 1991;19:512-7.
65. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-17.
66. Marik PE, Sibbaid WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993;269:3024-9.
67. Fitzgerald RD, Martin CM, Dietz GE, Doig GS, Potter RF, Sibbaid. Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit Care Med 1997;25:726-32.
68. Corwin HL, Rodriguez RM, Pearl RG, Corwin MJ, Enny C, Gettinger A. Erythropoietin response in critically ill patients. Abstract, Society of Critical Care Medicine, 1997.
69. Rodriguez RM, Corwin HL, Pearl RG, Corwin MJ, Enny C, Gettinger A. Iron, B12, and folate deficiency in ICU patients. Abstract, Society of Critical Care Medicine, 1997.
70. Gabriel A, Kozek S, Chiari A, Fitzgerald R, Grabner C, Geissler K, Zimpfer M, Stockenhuber F, Bircher NG. High dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma 1998;44:361-7.
71. Krafte-Jacobs B, Levetown ML, Bray GL, Ruttiman UE, Pollack MM. Erythropoietin response to critical illness. Crit Care Med 1994;22:821-6.
72. Rogiers P, Zhang H, Nagler J, Neels H, Melot C, Vincent JL. Erythropoietin response is blunted in critically ill patients. Intensive Care Med 1997;23:159-62.
73. Levine EA, Rosen AL, Sehgal LR, Gould SA, Egrie JC, Moss GS. Erythropoietin deficiency after coronary artery bypass procedures. Ann Thorac Surg 1991;51:764-6.
74. Goodnough LT, Brittenham. Limitations of the erythropoietic response to serial phlebotomy: Implications for autologous blood donor programs. J Lab Clin Med 1990;115:28-35.
75. Lorentz A, Jendrissek A, Eckardt KU, Schipplick M, Osswald PM, Kurtz A. Serial immunoreactive erythropoietin levels in autologous blood donors. Transfusion 1991;31:650-4.
76. Eschbach JW. The anemia of chronic renal failure. Pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989;35:134-48.
77. Lim VS. Recombinant human erythropoietin in predialysis patients. Am J Kidney Dis 1991;18 (Suppl 1):34-37.
78. Fischl M, Galpin JE, Levine JD, Groopman JE., Henry DH, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, Abels RI, Tsai HC, Rudnick SA. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990;322:1488-93.
79. Goodnough LT. Recombinant human erythropoietin therapy in the surgical setting and applications in oncology. Am J Kidney Dis 1991;18 (Suppl 1):98-102.
80. Pincus T, Olsen NJ, Russel IJ, Wolfe F, Harris ER, Schnitzer TJ, Boccagno JA, Krantz SB. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 1990;89:161-8.
81. Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 1990;322:1689-92.
82. Thompson FL, Powers JS, Graber SE, Krantz SB. Use of recombinant human erythropoietin to enhance autologous blood donation in patients with multiple red cell allo-antibodies and the anemia of chronic disease. Am J Med 1991;90:398-400.
83. Corwin HL, Rodriguez RM, Pearl RG, Corwin MJ, Enny C, Gettinger A. Efficacy of recombinant erythropoietin in critically ill patients: A randomized, double blind, placebo controlled trial. Crit Care Med In press.
84. Sowade O, Gross J, Sowade B, Warnke H, Franke W, Messinger D, Scigalla, Lun A, Glatzel E. Evaluation of oxygen availability with oxygen status algorithm in patients undergoing open heart surgery treated with epoetin beta. J Lab Clin Med 1997;129:97-105.
85. Nucci ML, Abuchowski A. The search for blood substitutes. Scientific Am 1998; 278:72-9.